Get the Stockscreener App
24.13
2.23%
-0.55
Staar Surgical Co stock is traded at $24.13, with a volume of 1.97M.
It is down -2.23% in the last 24 hours and down -6.65% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
See More
Previous Close:
$24.68
Open:
$24.4
24h Volume:
1.97M
Relative Volume:
1.83
Market Cap:
$1.19B
Revenue:
$224.45M
Net Income/Loss:
$-95.27M
P/E Ratio:
-12.50
EPS:
-1.93
Net Cash Flow:
$-43.74M
1W Performance:
-4.93%
1M Performance:
-6.65%
6M Performance:
+38.36%
1Y Performance:
-4.96%
1-Day Range:
$23.03
$24.54
1-Week Range:
$23.03
$27.53
52-Week Range:
$13.50
$30.81
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
24.13 | 1.22B | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
542.32 | 194.04B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.89 | 57.21B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.80 | 38.69B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.27 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.56 | 19.61B | 2.96B | 487.70M | 344.00M | 6.6758 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
Battle for STAAR Surgical intensifies as Glass Lewis reiterates stance ’against’ - Investing.com Australia
STAAR Surgical (STAA) Faces Investor Pushback on Alcon Offer - GuruFocus
Glass Lewis Reaffirms its Recommendations to Shareholders of STAAR - marketscreener.com
Glass Lewis reaffirms opposition to Alcon’s STAAR acquisition bid By Investing.com - Investing.com Australia
STAAR Surgical accuses activist Broadwood of ’misinformation campaign’ - Investing.com
STAAR Surgical Rebuts Investor Claims Over Alcon Deal Process - Finimize
Why STAAR Surgical (STAA) Stock Is Up Today - Finviz
STAAR addresses activist investor claims about go-shop process By Investing.com - Investing.com India
STAAR Surgical (STAA): Assessing Valuation After Recent Share Price Weakness - Yahoo Finance UK
Broadwood continues opposition to STAAR’s acquisition by Alcon - Investing.com
Canaccord Genuity Raises Price Target for STAA, Reaffirms Hold R - GuruFocus
STAAR Surgical falls as Yunqi Capital reiterates opposition to merger with Alcon - Investing.com India
STAAR Surgical's Top Investors Reject Sweetened Alcon Offer, Cite Flawed Sale Process - Benzinga
STAAR Surgical (NASDAQ:STAA) Shares Gap DownWhat's Next? - MarketBeat
Alcon sweetens offer for Staar, major shareholders still unimpressed - BioWorld MedTech
Yunqi Capital Comments on STAAR Surgical?s Go-Shop Process - marketscreener.com
STAAR Surgical Engages with its Employees - marketscreener.com
STAAR Surgical Acquisition by Alcon Opposed by Investor Yunqi Capital - marketscreener.com
Yunqi Capital opposes Alcon’s revised offer for STAAR Surgical - Investing.com India
Yunqi Capital opposes Alcon’s revised offer for STAAR Surgical By Investing.com - Investing.com Australia
Yunqi Capital comments on Staar Surgical's go-shop process and Alcon's revised offer - marketscreener.com
Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer - marketscreener.com
Switzerland: Alcon agrees best and final offer with STAAR Surgical - Investors in Healthcare
Alcon lifts bid for medical technology firm Staar to $1.6 billion - WHTC
Mergers and acquisitions - TradingView
STAAR Surgical stock jumps 10% after Alcon sweetens buyout offer — investor says deal is 'worth substantially more' - MSN
STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know - Yahoo Finance
Alcon bumps STAAR Surgical bid to $30.75, but Broadwood remains vehemently against - Investing.com
STAAR Surgical Stock Jumps 10% After Alcon Sweetens Buyout Offer — Investor Says Deal Is ‘Worth Substantially More’ - Stocktwits
Broadwood continues to oppose STAAR sale to Alcon despite price bump By Investing.com - Investing.com UK
Swiss eyecare giant Alcon lifts bid for rival Staar - Reuters
Alcon (NYSE: ALC) Faces Broadwood Pushback on Raised $30.75 STAAR Deal Offer - Stock Titan
Alcon Increases Offer to Acquire Staar to $1.6B - Orange County Business Journal
Stocks making the biggest moves midday: Exxon, SLM, CVS, AutoZone, Ares, Campbell's and more - CNBC
Academy Sports and Outdoors, Tronox, STAAR Surgical And Other Big Stocks Moving Higher On Tuesday - Benzinga
STAAR Surgical Company Enters into Amendment to the Agreement and Plan of Merger with Alcon - marketscreener.com
Alcon raises price target for STAAR Surgical stock to $30.75 in amended merger deal By Investing.com - Investing.com South Africa
Alcon raises price target for STAAR Surgical stock to $30.75 in amended merger deal - Investing.com
Staar Surgical raises merger offer price in amended agreement with Alcon - Investing.com Canada
Alcon, STAAR Amend Merger Agreement as Deal Looks Set to Move Forward - Medical Product Outsourcing
Alcon amends Staar merger agreement as deal looks set to move forward - MassDevice
Alcon raises offer to $30.75 per share in amended STAAR acquisition deal - Investing.com Australia
STAAR Surgical stock soars after Alcon raises acquisition offer By Investing.com - Investing.com Nigeria
STAAR Surgical stock soars after Alcon raises acquisition offer - Investing.com
Staar Surgical Amends Merger Agreement with Alcon - TipRanks
Staar Surgical raises merger offer price in amended agreement with Alcon By Investing.com - Investing.com South Africa
Alcon Announces Amended Merger Agreement with STAAR Surgical - Yahoo Finance
Egan-Jones reaffirms opposition to STAAR Surgical acquisition By Investing.com - Investing.com Australia
Why STAAR Surgical (STAA) Shares Are Plunging Today - Finviz
STAAR Surgical’s Sale To Alcon Faces Doubts And Pushback - Finimize
Broadwood urges STAAR shareholders to reject Alcon deal despite go-shop - Investing.com Canada
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Staar Surgical Co Stock (STAA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Nov 20 '25 |
Buy |
27.14 |
393,382 |
10,675,325 |
14,222,005 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Nov 19 '25 |
Buy |
26.42 |
309,132 |
8,166,155 |
13,828,623 |
| Jiang Wei | Director |
Nov 12 '25 |
Option Exercise |
0.00 |
20,967 |
0 |
45,477 |
| Jiang Wei | Director |
Aug 12 '25 |
Option Exercise |
0.00 |
20,967 |
0 |
24,510 |
1.32%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):